Avoro Capital Advisors LLC Ascendis Pharma A/S Transaction History
Avoro Capital Advisors LLC
- $5.48 Billion
- Q2 2025
A detailed history of Avoro Capital Advisors LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 4,980,000 shares of ASND stock, worth $975 Million. This represents 15.67% of its overall portfolio holdings.
Number of Shares
4,980,000
Previous 5,218,000
4.56%
Holding current value
$975 Million
Previous $813 Million
5.69%
% of portfolio
15.67%
Previous 13.16%
Shares
29 transactions
Others Institutions Holding ASND
# of Institutions
274Shares Held
60MCall Options Held
217KPut Options Held
60.3K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.01 Billion38.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.07 Billion4.42% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$867 Million0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$833 Million1.14% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.58MShares$702 Million0.39% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $10.9B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...